Raymond James & Associates’s Columbia Research Enhanced Core ETF RECS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$9.32M Buy
274,990
+30,105
+12% +$986K 0.01% 1272
2024
Q2
$7.9M Buy
244,885
+12,989
+6% +$403K 0.01% 1302
2024
Q1
$7.18M Buy
231,896
+133,926
+137% +$3.92M ﹤0.01% 1342
2023
Q4
$2.71M Buy
97,970
+15,608
+19% +$408K ﹤0.01% 1910
2023
Q3
$2.07M Buy
82,362
+30,590
+59% +$794K ﹤0.01% 2002
2023
Q2
$1.34M Buy
+51,772
New +$1.27M ﹤0.01% 2319

Other funds holding RECS

Raymond James & Associates's RECS Position: Q3 2024 in Review

Raymond James & Associates increased its Columbia Research Enhanced Core ETF (RECS) stake by 12% in Q3 2024, buying an estimated $986K and bringing the position to 274,990 shares worth $9.32M. The position accounts for 0.01% of the portfolio, ranked #1272.

Raymond James & Associates first reported a position in RECS in Q2 2023 and has held it in 6 quarters since. 67 funds tracked by Wall St. Rank hold RECS as of Q3 2024.

  • Raymond James & Associates held 274,990 shares of Columbia Research Enhanced Core ETF worth $9.32M as of Q3 2024.
  • Raymond James & Associates bought 30,105 Columbia Research Enhanced Core ETF shares in Q3 2024, an estimated $986K.
  • Columbia Research Enhanced Core ETF made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1272 holding.
  • Raymond James & Associates first reported a position in Columbia Research Enhanced Core ETF in Q2 2023 and has held it in 6 quarters since.
  • 67 funds tracked by Wall St. Rank held Columbia Research Enhanced Core ETF as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.